Mood regulation. GABA/glutamate co-release controls habenula output and is modified by antidepressant treatment.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 25237099.
- Also identified by DOI 10.1126/science.1250469 and PMC identifier 4305433.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The lateral habenula (LHb), a key regulator of monoaminergic brain regions, is activated by negatively valenced events. Its hyperactivity is associated with depression. Although enhanced excitatory input to the LHb has been linked to depression, little is known about inhibitory transmission. We discovered that γ-aminobutyric acid (GABA) is co-released with its functional opponent, glutamate, from long-range basal ganglia inputs (which signal negative events) to limit LHb activity in rodents. At this synapse, the balance of GABA/glutamate signaling is shifted toward reduced GABA in a model of depression and increased GABA by antidepressant treatment. GABA and glutamate co-release therefore controls LHb activity, and regulation of this form of transmission may be important for determining the effect of negative life events on mood and behavior.
Medical subject headings
- Antidepressive Agents
- Depression
- Glutamic Acid
- Habenula
- Synaptic Transmission
- gamma-Aminobutyric Acid